| 02/09/2024 |
Avis |
Preventive measures against mpox for travellers |
| 01/08/2024 |
Note |
Procedure regarding blood, organ, tissue or cell donors who have stayed in a country |
| 18/07/2024 |
Avis |
Solid organ harvesting in the context of seasonal flu and covid-19 |
| 21/06/2024 |
Avis |
Notice concerning the redeployment of an examination during the 1st month to create a new examination at the age of 6 |
| 29/05/2024 |
Note |
List of the “a priori” countries among EU and non-EU countries necessitating a temporary contraindication or screening measures related to WNV for donors who have stayed at least one night; season 2024 |
| 15/04/2024 |
Avis |
Vaccination and body management in the context of cholera in Mayotte |
| 25/01/2024 |
Avis |
High Council for Public Health opinion concerning the security of products derived from the human body regarding the risk of transmission of the Usutu virus |
| 21/12/2023 |
Avis |
High Council for Public Health opinion concerning proposals for changing the scientific framework relating to the conditions of use, particularly on an exceptional basis, of organs and tissues from donors carrying markers of infection by hepatitis B (HBV |
| 08/11/2023 |
Avis |
Action to be taken in the event of the presence of several pesticides and relevant pesticide metabolites in water intended for human consumption |
| 30/10/2023 |
Avis |
Use of water from the bottom of hillside reservoirs in Mayotte to produce water for human consumption |
| 20/10/2023 |
Note |
Inclusion of Morocco on the list of countries at risk of WNV infection for human body products donation |
| 05/10/2023 |
Note |
Biological test in case of cured syphilis in candidates for blood donation |
| 26/09/2023 |
Avis |
Use of "disinfectant tablets" in Mayotte in the context of a long-lasting drought episode |
| 07/09/2023 |
Avis |
Opinion on what to do in the event of accidents involving exposure to prions and propagons and in the context of care involving invasive procedures |
| 31/08/2023 |
Avis |
Opinion regarding the risk of contamination with Strongyloides stercoralis following transplantation of human body products |
| 07/08/2023 |
Note |
Tick-borne encephalitis virus (TBEV) – Update of the French High Council for Public Health opinion of July 23, 2020 |
| 11/07/2023 |
Avis |
Referral related to systematic screening for cytomegalovirus in gamete and embryo donors |
| 06/07/2023 |
Avis |
Update of the HCSP opinions issued during the Covid-19 health crisis concerning the management of healthcare waste |
| 22/06/2023 |
Avis |
Timeliness of a vaccination campaign in Mayotte (shortage of drinking water) |
| 16/06/2023 |
Avis |
Funeral risks and respiratory viruses |
| 01/06/2023 |
Avis |
New recommendations for sorting healthcare waste in connection with the revision of the national guide on the elimination of waste from healthcare activities |
| 01/06/2023 |
Avis |
Opinion regarding the maintenance of combustion appliances and chimney sweeping |
| 20/04/2023 |
Avis |
Referral related to prevention measures to be taken due to the risk of transmission of hepatitis E virus (HEV) from donors of products or elements of the human body |
| 06/04/2023 |
Avis |
Opinion on the drafting of the National Food, Nutrition and Climate Strategy (SNANC) |
| 28/03/2023 |
Avis |
Securing human body products in anticipation of the circulation of the West-Nile virus in metropolitan France |
| 13/01/2023 |
Avis |
Statement on measures of security for human body products owing to a human case report of West Nile virus (WNV) infection in mainland France outside the seasonal alert period |
| 30/12/2022 |
Avis |
Update of the opinions on the safety of human body products in the fields of transplantation and MPA with regard to Covid-19 |
| 16/12/2022 |
Avis |
Notice on the mandatory reporting of leptospirosis |
| 21/10/2022 |
Avis |
Treatment of sewage sludge in relation to the risk of SARS-CoV-2 infection |
| 19/10/2022 |
Avis |
Securing human body products in the context of the occurrence of autochthonous dengue cases in the south of France |
| 29/07/2022 |
Avis |
Canine olfactory screening in the screening strategy of SARS-CoV-2 infection |
| 08/07/2022 |
Avis |
Preventive measures against Monkeypox virus infection |
| 21/06/2022 |
Avis |
Statement on the coverage of vitamin D and iron requirements of the general population |
| 09/06/2022 |
Avis |
Prevention of monkeypox virus transmission through labile blood products, grafts and other human body products and components |
| 09/06/2022 |
Avis |
What to do for people at risk of severe Monkeypox virus infection |
| 24/05/2022 |
Avis |
What to do after the occurrence of a suspected, probable or confirmed case of Monkeypox virus infection |
| 28/04/2022 |
Avis |
Implementation of preventive measures against the transmission of the Ebola virus through human body products and parts |
| 28/04/2022 |
Avis |
Measures to prevent the risks associated with the Zika virus and the dengue virus in the field of medically assisted procreation (MPA) |
| 22/04/2022 |
Avis |
Health impacts of the possible use of non-conventional water as a substitute for water intended for human consumption |
| 19/04/2022 |
Avis |
Sedentary lifestyles and physical activity in the aftermath of a health crisis |
| 15/04/2022 |
Avis |
Number of masks, respirators and other personal protective equipment to be kept in State stock |
| 11/04/2022 |
Avis |
Use of Evusheld® for pre-exposure prophylaxis of Covid-19 |
| 01/04/2022 |
Avis |
Prevention of invasive infections in patients treated with complement inhibitors |
| 23/03/2022 |
Avis |
Public health issues and health Rendezvous for migrants from conflict zones in Ukraine |
| 18/03/2022 |
Avis |
Management of health risks related to pesticides and pesticide metabolites in water intended for human consumption |
| 03/03/2022 |
Avis |
Barrier measures and tuberculosis: definition of contacts and case investigation |
| 11/02/2022 |
Avis |
Evolution of the doctrine of testing and isolation of cases and contacts in the context of the declining spread of the Omicron variant of Sars-CoV-2 |
| 11/02/2022 |
Avis |
Update of selection criteria for donors of labile blood products and tissues in the context of a Covid-19 pandemic with a predominant circulation of the Omicron variant of SARS-CoV-2 |
| 27/01/2022 |
Synthèse |
Avis relatif aux usages et bon usage de la mesure de la santé perçue et de la qualité de vie en France |
| 21/01/2022 |
Avis |
Notice relating to the measurement of carbon dioxide in the indoor air of establishments open to the public |
| 18/01/2022 |
Avis |
Revision of the dietary guidelines for pregnant and breastfeeding women |
| 07/01/2022 |
Avis |
FFP2 respiratory protective devices for health professionals in the context of the fight against the spread of the SARS-CoV-2 virus in relation to the emergence of the Omicron variant (supplement) |
| 23/12/2021 |
Avis |
FFP2 respiratory protective devices in the general population to fight against the spread of the SARS-CoV-2 virus in relation to the emergence of the Omicron variant |
| 10/12/2021 |
Avis |
Statement on the prevention of the transmission of swine and avian influenza viruses to humans |
| 26/11/2021 |
Avis |
Report on the benefits and risks of electronic cigarettes |
| 26/11/2021 |
Avis |
Report on the benefits and risks of electronic cigarettes |
| 20/10/2021 |
Avis |
Management of patients with suspected viral haemorrhagic fever, including Ebola virus disease |
| 08/10/2021 |
Avis |
Evaluation of the future 2022-2025 infection and antibiotic resistance prevention strategy |
| 06/08/2021 |
Avis |
Strategy for the State’s stock of masks and personal protective equipment |
| 22/07/2021 |
Avis |
Measures to prevent the risks associated with the SARS-CoV-2 virus in the field of medically-assisted procreation |
| 06/07/2021 |
Avis |
Protection of the population with stable iodine in the event of a nuclear accident |
| 05/07/2021 |
Avis |
Statement concerning the management of new situations of exposure to extreme heatwaves - general recommendations |
| 18/06/2021 |
Avis |
Covid-19: contact tracing and barrier measures for fully vaccinated persons |
| 17/06/2021 |
Avis |
Covid-19: IL1 and IL6 antagonist treatment recommendations |
| 16/06/2021 |
Avis |
List of countries at risk of West Nile virus (WNV) transmission for donations of human body products |
| 11/06/2021 |
Avis |
Hantavirus infections and risks for donations of human body products |
| 16/05/2021 |
Avis |
Covid-19: persistent symptoms post Covid-19 |
| 11/05/2021 |
Avis |
Occupational activity of persons at risk of severe Covid-19 who have received a full vaccination schedule |
| 03/05/2021 |
Avis |
Safety of organ, tissue and cell donations from donors who have been vaccinated for less than one month with an anti-SARS-CoV-2 vaccine |
| 03/05/2021 |
Avis |
Securing donations of human body products against dengue fever in the French West Indies, Reunion Island and Metropolitan France |
| 28/04/2021 |
Avis |
Covid-19 : aeration, ventilation and CO2 measurement in Public Accesses Buildings (PAB) |
| 23/04/2021 |
Avis |
Covid-19 : Incineration of waste from care activities with infectious risks (WFIW) and rationalisation of WFIW |
| 18/04/2021 |
Avis |
Covid-19: strategy for defining measures to allow the reopening of Public Accesses Buildings (PAB) |
| 16/04/2021 |
Avis |
Health recommendations 2021 for travellers (for the attention of health professionals) |
| 15/04/2021 |
Avis |
Cell, tissue and organ donor selection in response to new SARS-CoV-2 variants |
| 02/04/2021 |
Avis |
Covid-19: adaptation of isolation recommendations for professionals in health care institutions or social and medico-social establishments (EMS) |
| 23/03/2021 |
Avis |
Covid-19: treatment guidelines: tocilizumab and monoclonal antibodies (updated 23/03/2021) |
| 09/03/2021 |
Avis |
Cell, Tissue and Organ Donor Selection in the Context of Pandemic Covid-19 |
| 02/03/2021 |
Avis |
Covid-19: Organization of prevention in nursing homes (NHs) and in long term care facilities (LTCFs) |
| 01/03/2021 |
Avis |
Covid-19: Prioritization of iterative salivary tests |
| 03/02/2021 |
Avis |
Covid-19: Monitoring and preventing the spread of new virus variants in health care settings |
| 02/02/2021 |
Avis |
Deferral criteria for donors with Covid-19 vaccination |
| 28/01/2021 |
Avis |
Recommendations for the sterilization of baby bottles in health care facilities |
| 28/01/2021 |
Avis |
Covid-19: treatment recommendations (updated 28/01/2021) |
| 28/01/2021 |
Rapport |
Controlling the risk associated with lead in the outdoor environment |
| 20/01/2021 |
Avis |
Covid-19: monitoring the spread of new virus variants (supplement) |
| 14/01/2021 |
Avis |
Covid-19: monitoring the spread of new virus variants |
| 17/12/2020 |
Avis |
Covid-19: Delay in patient’s transfer to a follow-up care service or a nursing home (NH) (additional guidelines) |
| 15/12/2020 |
Avis |
Risks of tattooing and tattoo removal products and practices |
| 09/12/2020 |
Avis |
Covid-19: Sanitary conditions for the end-of-year celebrations 2020 |
| 28/11/2020 |
Avis |
Notice concerning the updating of prevention measures against the dengue virus to be applied to products derived from the human body in the Fren |
| 22/11/2020 |
Avis |
Covid-19: Evaluation of a strengthened health protocol for shops |
| 13/11/2020 |
Avis |
Prophylaxis of invasive meningococcal disease in patients treated with ravulizumab and eculizumab |
| 06/11/2020 |
Avis |
Transfusion and transplant safety following indigenous dengue cases |
| 29/10/2020 |
Avis |
Covid-19: update of the list of risk factors for severe forms |
| 29/10/2020 |
Avis |
Masks in the fight against the spread of SARS-CoV-2 |
| 24/10/2020 |
Avis |
SARS-CoV-2: Cell, tissue and organ donors |
| 23/10/2020 |
Avis |
Covid-19: transfer delay of Covid-19 patients towards follow-up care service or a retirement home |
| 20/10/2020 |
Avis |
Coronavirus SARS-CoV-2: recommendations on barrier measures for physical activity and sport |
| 19/10/2020 |
Avis |
Use of dexamethasone and other corticosteroids in Covid-19 |
| 14/10/2020 |
Avis |
French Guidelines on the Use of Heaters during the Covid-19 Epidemic |
| 14/10/2020 |
Avis |
French Guidelines on the Use of Heaters during the Covid-19 Epidemic |
| 11/10/2020 |
Avis |
Covid-19 screening strategies in health and medico-social establishments |
| 06/10/2020 |
Avis |
Covid-19 : pregnant women and work |
| 25/09/2020 |
Avis |
What to do following the discovery of animal tuberculosis with Mycobacterium bovis? |
| 25/09/2020 |
Avis |
Notice on post-exposure treatment of rabies |
| 17/09/2020 |
Avis |
Covid-19: co-circulation of SARS-CoV-2 and winter viruses |
| 17/09/2020 |
Avis |
Covid-19: Complementary recommendations on strategies to prevent the spread of SARS-CoV-2 in child care and school settings |
| 17/09/2020 |
Rapport |
Statement and report on the in itinere evaluation of the National Public Health Plan |
| 09/09/2020 |
Avis |
Covid-19: recommendations on masks within child care settings |
| 28/08/2020 |
Avis |
Collective enclosed spaces and Covid-19: mask wearing and possible adaptations at the workplace |
| 23/08/2020 |
Avis |
Sports and cultural events: wearing masks to prevent Covid-19 |
| 20/08/2020 |
Avis |
Covid-19: recommendations for masks in enclosed public spaces |
| 11/08/2020 |
Avis |
Covid-19: oropharyngeal swabs and pooling |
| 23/07/2020 |
Avis |
SARS-CoV-2: Updates on aerosol transmission of the virus |
| 23/07/2020 |
Avis |
Covid-19: people at risk of developing severe forms of the disease |
| 25/06/2020 |
Avis |
Covid-19: Remdesivir (updated on 31 May 2020) |
| 22/06/2020 |
Avis |
Phase 3 containment lifting for companies |
| 18/06/2020 |
Avis |
Managing the Covid-19 epidemic and social inequalities in children’s health, lessons for the future |
| 09/05/2020 |
Avis |
Notice concerning the link between smoking and Covid-19 |
| 06/05/2020 |
Avis |
Statement on management of the Covid-19 epidemic in the event of the population’s exposure to heatwaves |
| 06/05/2020 |
Avis |
Coronavirus SARS-CoV-2: managing the epidemic in the event of heat waves |
| 06/05/2020 |
Avis |
Coronavirus SARS-CoV-2: recommendations relating to textiles, and to footwear and clothing retail outlets |
| 05/05/2020 |
Avis |
The Covid-19 epidemic: lifting the lockdown for individuals with disabilities |
| 01/05/2020 |
Avis |
Covid-19: bathing water and the use of water from the natural environment |
| 29/04/2020 |
Avis |
Coronavirus SARS-CoV-2: risks linked to the reuse and prolonged wearing of single-use face masks |
| 28/04/2020 |
Avis |
Temperature-taking to control access within the context of the Covid-19 epidemic |
| 24/04/2020 |
Avis |
Coronavirus SARS-CoV-2: Barrier and physical distancing measures for the general population |
| 08/04/2020 |
Avis |
Statement on the management at home or in a care facility of suspected or confirmed Covid-19 patients (supplementing the statements dated 5 and |
| 08/04/2020 |
Avis |
Statement on the management of waste containing adult incontinence products used by possible, probable and confirmed Covid-19 patients |
| 04/04/2020 |
Avis |
Statement on the opportunity for specific cleaning or disinfection of the pavements and public spaces |
| 01/04/2020 |
Synthèse |
Elaboration of a tool to characterize a housing in regard with health “Domiscore” Executive summary |
| 31/03/2020 |
Avis |
Statement on prevention and management of patients at risk of severe forms of Covid-19 and on priority access to diagnostic tests |
| 31/03/2020 |
Avis |
Statement on the protection of waste collection workers during the Covid-19 epidemic |
| 30/03/2020 |
Avis |
Statement on support for disabled people during the Covid-19 epidemic and the extended confinement period |
| 30/03/2020 |
Avis |
Coronavirus SARS-CoV-2: caring for people living in precarious circumstances |
| 24/03/2020 |
Avis |
SARS coronavirus-2: safe handling of bodies of deceased persons with suspected or confirmed Covid-19 |
| 23/03/2020 |
Avis |
SARS-CoV-2: therapeutic recommendations |
| 19/03/2020 |
Avis |
Management of clinical waste generated during the COVID-19 epidemic, particularly in the community |
| 17/03/2020 |
Avis |
Reducing the risk of SARS-CoV-2 transmission through ventilation and management of patients’ bodily fluids |
| 16/03/2020 |
Avis |
SARS coronavirus-2: clinical criteria for safely ending isolation of infected patients |
| 14/03/2020 |
Avis |
Provisional statement: Recommendations on prevention and management of Covid-19 in patients at risk of severe forms |
| 10/03/2020 |
Avis |
Provisional statement: Patients at risk of severe forms of Covid-19 and prioritising access to diagnostic tests |
| 05/03/2020 |
Avis |
Covid-19: management of confirmed cases |
| 24/02/2020 |
Avis |
Maintaining safe donations of blood, cells, tissue and organs while SARS-CoV-2 is actively circulating |
| 24/02/2020 |
Note |
Élaboration d’un outil de caractérisation d’un habitat du point de vue de la santé – « Domiscore » Rapport de faisabilité |
| 24/02/2020 |
Annexe |
Élaboration d’un outil de caractérisation d’un habitat du point de vue de la santé – « Domiscore » Rapport de faisabilité |
| 24/02/2020 |
Annexe |
Élaboration d’un outil de caractérisation d’un habitat du point de vue de la santé – « Domiscore » Rapport de faisabilité |
| 18/02/2020 |
Avis |
SARS coronavirus-2 (SARS-CoV-2): cleaning the premises of a confirmed patient and protecting staff |
| 14/06/2019 |
Avis |
On the measures for treating patients infected or colonised by Candida auris and on the benefit/risk ratio of prescribing prophylactic antifunga |
| 14/06/2019 |
Avis |
Dengue and Chikungunya: measures relating to the safety of blood transfusions and transplants |
| 23/05/2019 |
Avis |
West Nile: measures relating to the safety of blood transfusions and transplants |
| 02/05/2019 |
Synthèse |
Benchmarks for managing indoor air quality for formaldehyde |
| 02/05/2019 |
Rapport |
Benchmarks for managing indoor air quality for formaldehyde |
| 02/05/2019 |
Avis |
Benchmarks for managing indoor air quality for formaldehyde |
| 09/04/2019 |
Rapport |
Indications of non-pharmaceutical interventions to control the spread of transmissible infectious diseases |
| 22/03/2019 |
Avis |
Statement on 2019 health recommendations for travellers (for the attention of health professionals) |
| 28/02/2019 |
Avis |
Statement on the screening for urogenital schistosomiasis in populations visiting the rivers Cavu and Solenzara in south Corsica |
| 20/11/2018 |
Rapport |
Critical analysis of the draft National Strategy on Endocrine Disruptors 2 (SNPE2) and proposal of result indicators |
| 07/09/2018 |
Avis |
Management of clusters of invasive Kingella kingae infections in daycare facilities for children |
| 07/09/2018 |
Avis |
Indications for monoclonal antibody and antiviral treatment on a preventive and curative basis in health workers exposed to the Ebola virus |
| 22/06/2018 |
Avis |
Development of recommendations to authorize the release of irradiated sterile mosquitoes for the purposes of vector control |
| 22/06/2018 |
Avis |
Preventive measures via immunization against the Ebola virus of individuals likely to come into contact with patients at risk of transmission |
| 18/05/2018 |
Avis |
Use of primaquine as a radical treatment for P. vivax and P. ovale malaria in France |
| 18/05/2018 |
Avis |
Determination of an endemic threshold for tuberculosis |
| 18/05/2018 |
Avis |
Establishment of compulsory declaration of MERS-CoV infections |
| 17/05/2018 |
Rapport |
Evaluation of the 2013-2017 national patient safety programme |
| 29/04/2018 |
Rapport |
Protecting workers and persons living next to sites where titanium dioxide nanoparticles are produced or processed |
| 23/04/2018 |
Avis |
Statement on the management strategy through a major measles outbreak within France |
| 26/03/2018 |
Avis |
Statement on scientific and technical support relating to the recast of amended Directive 98/83/EC on the quality of water intended for human consumption |
| 16/03/2018 |
Avis |
Statement on the use of primaquine for altruistic purposes against Plasmodium falciparum malaria in Mayotte |
| 16/03/2018 |
Avis |
Prescription of antivirals in cases of seasonal influenza |
| 08/02/2018 |
Avis |
Statement on the assessment of the health strategy for persons placed under judicial control (PPJC |
| 22/12/2017 |
Rapport |
Prevention of Alzheimer’s disease and related diseases (ADRD) |
| 21/12/2017 |
Avis |
Statement on the medical care provided for and the monitoring of new-borns and infants having been exposed to the Zika virus in utero or present |
| 29/11/2017 |
Avis |
Statement on the referral dated 6 November 2017 on the draft for the French National Health Strategy |
| 13/10/2017 |
Avis |
Polioviruses and their potential introduction on lists of transmissible infections requiring or prohibiting certain funerary operations |
| 13/09/2017 |
Avis |
“Altruistic” use of Primaquine and Plasmodium falciparum malaria in French Guiana |
| 12/09/2017 |
Rapport |
For a public health nutrition policy in France. PNNS 2017-2021 |
| 08/09/2017 |
Rapport |
Statement on the National Health Strategy: Contribution of the French High Council for Public Health |
| 27/06/2017 |
Avis |
Information update on the risk of Borrelia transmission via labile blood products and grafts |
| 21/06/2017 |
Avis |
Medical certificate of no contraindication to the practice of sports for children, following Decree no.2016-1157 of 24 August 2016 |
| 23/05/2017 |
Avis |
Additional information regarding the measures to control the spread of emergent highly-resistant bacteria (eHRB) recommended in the opinion of the French HCPH of 27 September 2016 in view of the emergence of a plasmid mediated (mcr-1) colistin resistance in Enterobacteriaceae |
| 13/03/2017 |
Rapport |
Territorial Hospital Groups and public health |
| 16/02/2017 |
Avis |
Statement related to the revision of the 2017-2021 French Nutrition and Health Programme’s dietary guidelines for adults |
| 06/12/2016 |
Avis |
Microbiological diagnosis of carbapenemase-producing Enterobacteriaceae or colistin-resistant Enterobacteriaceae carrying the mcr-1 gene |
| 01/12/2016 |
Rapport |
Proposal of targets and indicators concerning the expected outcomes of the 3rd National Environmental Health Action Plan |
| 27/09/2016 |
Avis |
Measures to be taken with regard to the emergence of a plasmid-mediated resistance to (mcr-1) colistin in Enterobacteriaceae |
| 28/04/2016 |
Avis |
Information and recommendations to be issued with a view to preventing health risks associated with allergenic pollen |
| 22/02/2016 |
Avis |
Opinion concerning the risks and benefits in the use of electronic cigarettes by the general population |
| 25/06/2015 |
Avis |
On information regarding the nutritional quality of foodstuffs |
| 04/12/2014 |
Avis |
Management of health-care worker (HCW) in care settings who are victims of an AEB/AEV from a patient who is a confirmed index case of Ebola virus disease |
| 08/07/2014 |
Avis |
Booster vaccination against poliomyelitis for some travellers in the context of the current public health emergency declared by the WHO |
| 23/05/2014 |
Synthèse |
Lead exposure: determination of new risk management objectives |
| 25/04/2014 |
Avis |
Opinion concerning the risks and benefits in the use of electronic cigarettes by the general population |
| 15/11/2013 |
Avis |
Public health messages to be issued during episodes of pollution by particles, ozone, nitrogen dioxide and/or sulphur dioxide |
| 06/02/2013 |
Synthèse |
Indicators of "premature" and "avoidable" mortality |
| 19/01/2013 |
Synthèse |
Evaluation of the second national environmental health action plan - summary and recommendations |
| 21/12/2012 |
Avis |
Simplification of the French vaccination schedule |
| 13/04/2012 |
Synthèse |
Particulate matter in outdoor air pollution : Summary and recommendations for protecting health |
| 20/02/2012 |
Synthèse |
Mid-term evaluation of the 2009-2013 cancer plan |
| 07/12/2011 |
Avis |
Health policies in schools - Summary and recommendations for promoting students’ health |
| 02/12/2011 |
Avis |
Defining indications for the unavoidable use of sterile bottles and teats when feeding hospitalised infants and newborns |
| 18/11/2011 |
Avis |
Difficulties of producing solvent/detergent-treated plasma and on the arrangements for best meeting national therapeutic plasma needs |
| 21/10/2011 |
Synthèse |
Towards a global and integrated patient safety policy: Principles and recommendations |
| 14/06/2011 |
Synthèse |
Prevention of the healthcare worker-to-patient HBV, HCV, HIV transmission |
| 15/03/2011 |
Synthèse |
Evaluation of the National Program for improving pain management 2006 - 2010 |
| 04/02/2011 |
Synthèse |
Evaluation of the plan for preserving antibiotic efficacy 2007 - 2010 |
| 21/12/2010 |
Synthèse |
Évaluation des risques sanitaires dans les analyses de zone. Utilité, lignes méthodologiques et interprétation - Annexe 4 - International workshop synthesis english version |
| 21/12/2010 |
Rapport |
Health risk assessment in zone analyses. Utility, methodological issues and interpretation |
| 09/12/2010 |
Synthèse |
Assessment of the French National Plan on Healthy Ageing 2007-2009. Synthesis and recommendations |
| 02/02/2010 |
Rapport |
Recommendations relating to measures to be implemented to prevent the emergence of ESBL enterobacteriacae and fight against their spread
Proposals written up from the point of view of defining a national prevention programme |
| 12/11/2009 |
Synthèse |
Report on Therapeutic education within primary care - Synthesis and recommendations |
| 17/03/2009 |
Synthèse |
Assessment of National Rare Diseases Plan 2005-2008. Synthesis - April 2009 |
